@article{dequen_systematic_2012-1,
	title = {Systematic {Review} and {Network} {Meta}-{Analysis} of {Overall} {Survival} {Comparing} 3 mg/kg {Ipilimumab} {With} {Alternative} {Therapies} in the {Management} of {Pretreated} {Patients} {With} {Unresectable} {Stage} {III} or {IV} {Melanoma}},
	volume = {17},
	issn = {1083-7159, 1549-490X},
	url = {http://theoncologist.alphamedpress.org/lookup/doi/10.1634/theoncologist.2011-0427},
	doi = {10.1634/theoncologist.2011-0427},
	abstract = {Objective. To compare the overall survival (OS) of patients treated with 3 mg/kg ipilimumab versus alternative systemic therapies in pretreated unresectable stage III or IV melanoma patients.},
	language = {en},
	number = {11},
	urldate = {2019-05-02},
	journal = {The Oncologist},
	author = {Dequen, Pascale and Lorigan, Paul and Jansen, Jeroen P. and van Baardewijk, Marc and Ouwens, Mario J.N.M. and Kotapati, Srividya},
	month = nov,
	year = {2012},
	keywords = {Antibodies, Antineoplastic Agents, Antineoplastic Combined Chemotherapy Protocols, Humans, Immunotherapy, Ipilimumab, Kaplan-Meier Estimate, Melanoma, Monoclonal, Neoplasm Staging, oncology, Skin Neoplasms, Survival Analysis, Treatment Outcome},
	pages = {1376--1385},
	file = {Dequen et al. - 2012 - Systematic Review and Network Meta-Analysis of Ove.pdf:/Users/neil.hawkins/Zotero/storage/KVILTLV5/Dequen et al. - 2012 - Systematic Review and Network Meta-Analysis of Ove.pdf:application/pdf},
}

{"_id":"Z2wfnxFmnXMrqK3Ay","bibbaseid":"dequen-lorigan-jansen-vanbaardewijk-ouwens-kotapati-systematicreviewandnetworkmetaanalysisofoverallsurvivalcomparing3mgkgipilimumabwithalternativetherapiesinthemanagementofpretreatedpatientswithunresectablestageiiiorivmelanoma-2012","authorIDs":[],"author_short":["Dequen, P.","Lorigan, P.","Jansen, J. P.","van Baardewijk, M.","Ouwens, M. J.","Kotapati, S."],"bibdata":{"bibtype":"article","type":"article","title":"Systematic Review and Network Meta-Analysis of Overall Survival Comparing 3 mg/kg Ipilimumab With Alternative Therapies in the Management of Pretreated Patients With Unresectable Stage III or IV Melanoma","volume":"17","issn":"1083-7159, 1549-490X","url":"http://theoncologist.alphamedpress.org/lookup/doi/10.1634/theoncologist.2011-0427","doi":"10.1634/theoncologist.2011-0427","abstract":"Objective. To compare the overall survival (OS) of patients treated with 3 mg/kg ipilimumab versus alternative systemic therapies in pretreated unresectable stage III or IV melanoma patients.","language":"en","number":"11","urldate":"2019-05-02","journal":"The Oncologist","author":[{"propositions":[],"lastnames":["Dequen"],"firstnames":["Pascale"],"suffixes":[]},{"propositions":[],"lastnames":["Lorigan"],"firstnames":["Paul"],"suffixes":[]},{"propositions":[],"lastnames":["Jansen"],"firstnames":["Jeroen","P."],"suffixes":[]},{"propositions":["van"],"lastnames":["Baardewijk"],"firstnames":["Marc"],"suffixes":[]},{"propositions":[],"lastnames":["Ouwens"],"firstnames":["Mario","J.N.M."],"suffixes":[]},{"propositions":[],"lastnames":["Kotapati"],"firstnames":["Srividya"],"suffixes":[]}],"month":"November","year":"2012","keywords":"Antibodies, Antineoplastic Agents, Antineoplastic Combined Chemotherapy Protocols, Humans, Immunotherapy, Ipilimumab, Kaplan-Meier Estimate, Melanoma, Monoclonal, Neoplasm Staging, oncology, Skin Neoplasms, Survival Analysis, Treatment Outcome","pages":"1376–1385","file":"Dequen et al. - 2012 - Systematic Review and Network Meta-Analysis of Ove.pdf:/Users/neil.hawkins/Zotero/storage/KVILTLV5/Dequen et al. - 2012 - Systematic Review and Network Meta-Analysis of Ove.pdf:application/pdf","bibtex":"@article{dequen_systematic_2012-1,\n\ttitle = {Systematic {Review} and {Network} {Meta}-{Analysis} of {Overall} {Survival} {Comparing} 3 mg/kg {Ipilimumab} {With} {Alternative} {Therapies} in the {Management} of {Pretreated} {Patients} {With} {Unresectable} {Stage} {III} or {IV} {Melanoma}},\n\tvolume = {17},\n\tissn = {1083-7159, 1549-490X},\n\turl = {http://theoncologist.alphamedpress.org/lookup/doi/10.1634/theoncologist.2011-0427},\n\tdoi = {10.1634/theoncologist.2011-0427},\n\tabstract = {Objective. To compare the overall survival (OS) of patients treated with 3 mg/kg ipilimumab versus alternative systemic therapies in pretreated unresectable stage III or IV melanoma patients.},\n\tlanguage = {en},\n\tnumber = {11},\n\turldate = {2019-05-02},\n\tjournal = {The Oncologist},\n\tauthor = {Dequen, Pascale and Lorigan, Paul and Jansen, Jeroen P. and van Baardewijk, Marc and Ouwens, Mario J.N.M. and Kotapati, Srividya},\n\tmonth = nov,\n\tyear = {2012},\n\tkeywords = {Antibodies, Antineoplastic Agents, Antineoplastic Combined Chemotherapy Protocols, Humans, Immunotherapy, Ipilimumab, Kaplan-Meier Estimate, Melanoma, Monoclonal, Neoplasm Staging, oncology, Skin Neoplasms, Survival Analysis, Treatment Outcome},\n\tpages = {1376--1385},\n\tfile = {Dequen et al. - 2012 - Systematic Review and Network Meta-Analysis of Ove.pdf:/Users/neil.hawkins/Zotero/storage/KVILTLV5/Dequen et al. - 2012 - Systematic Review and Network Meta-Analysis of Ove.pdf:application/pdf},\n}\n\n","author_short":["Dequen, P.","Lorigan, P.","Jansen, J. P.","van Baardewijk, M.","Ouwens, M. J.","Kotapati, S."],"bibbaseid":"dequen-lorigan-jansen-vanbaardewijk-ouwens-kotapati-systematicreviewandnetworkmetaanalysisofoverallsurvivalcomparing3mgkgipilimumabwithalternativetherapiesinthemanagementofpretreatedpatientswithunresectablestageiiiorivmelanoma-2012","role":"author","urls":{"Paper":"http://theoncologist.alphamedpress.org/lookup/doi/10.1634/theoncologist.2011-0427"},"keyword":["Antibodies","Antineoplastic Agents","Antineoplastic Combined Chemotherapy Protocols","Humans","Immunotherapy","Ipilimumab","Kaplan-Meier Estimate","Melanoma","Monoclonal","Neoplasm Staging","oncology","Skin Neoplasms","Survival Analysis","Treatment Outcome"],"metadata":{"authorlinks":{}}},"bibtype":"article","biburl":"https://bibbase.org/f/FfNE7kWA6pCvwcJZF/myPubs.bib","creationDate":"2019-10-29T15:53:48.223Z","downloads":0,"keywords":["antibodies","antineoplastic agents","antineoplastic combined chemotherapy protocols","humans","immunotherapy","ipilimumab","kaplan-meier estimate","melanoma","monoclonal","neoplasm staging","oncology","skin neoplasms","survival analysis","treatment outcome"],"search_terms":["systematic","review","network","meta","analysis","overall","survival","comparing","ipilimumab","alternative","therapies","management","pretreated","patients","unresectable","stage","iii","melanoma","dequen","lorigan","jansen","van baardewijk","ouwens","kotapati"],"title":"Systematic Review and Network Meta-Analysis of Overall Survival Comparing 3 mg/kg Ipilimumab With Alternative Therapies in the Management of Pretreated Patients With Unresectable Stage III or IV Melanoma","year":2012,"dataSources":["usc9shidSEoJgjLwM","ZaHtWavQhcwZqKLNF","iRRNaRs6FkffgErta","zeMwFvgpdRkYAkfoD","v8uQmZsBpiqycmskv"]}